Patents by Inventor Colin Diner

Colin Diner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250257063
    Abstract: The present disclosure provides DCN-1 modulating compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions, and their use for treating sickle cell disorders, diseases, and conditions. Such compounds are of Formula I: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 16, 2025
    Publication date: August 14, 2025
    Inventors: Robert Brian Nicewonger, Mauricio Cortes, Colin Diner, Ragy Haddad, Sriram Krishnamoorthy, Na Li, Frank Lovering, Kristen Marino, Samuel Miller, Qing Tang, Atli Thorarensen, Ravi Ujjinamatada, David Zhang
  • Publication number: 20250163058
    Abstract: The present disclosure provides DCN-1 modulating compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions, and their use for treating sickle cell disorders, diseases, and conditions. Such compounds are of Formula Ia: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 1, 2024
    Publication date: May 22, 2025
    Inventors: Robert Brian Nicewonger, Mauricio Cortes, Colin Diner, Sriram Krishnamoorthy, Na Li, Frank Lovering, Kristen Marino, Samuel Miller, Qing Tang, Atli Thorarensen, Ravi Ujjinamatada, David Zhang
  • Publication number: 20250163057
    Abstract: The present disclosure provides DCN-1 modulating compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions, and their use for treating sickle cell disorders, diseases, and conditions. Such compounds are of Formula I: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 1, 2024
    Publication date: May 22, 2025
    Inventors: Robert Brian Nicewonger, Mauricio Cortes, Colin Diner, Ragy Haddad, Sriram Krishnamoorthy, Na Li, Frank Lovering, Kristen Marino, Samuel Miller, Qing Tang, Atli Thorarensen, Ravi Ujjinamatada, David Zhang
  • Publication number: 20230115176
    Abstract: The present disclosure presents compounds and compositions that interact with complement components. Some compounds inhibit complement activity. Included are small molecule compounds and compositions that function as C5 inhibitor compounds. Methods for inhibiting complement activity and methods of treating complement-related indications with the C5 inhibitor compounds and compositions are provided.
    Type: Application
    Filed: March 27, 2020
    Publication date: April 13, 2023
    Inventors: Willmen Wing-Menn Youngsaye, Bolin Geng, Michael R. Hale, Vincent P. Galullo, Jayashree G. Tikhe, Timothy Ryan Siegert, Alonso Ricardo, Derek M. LaPlaca, Douangsone D. Vadysirisack, Guo-Qing Tang, Kathleen Seyb, Michelle Denise Hoarty, Jonathan C. Blain, Joseph R. Stringer, Yongjin Gong, Claudio Sturino, Shawn Gallagher-Duval, Colin Diner, Burcin Akgun, Qing Cao, Douglas A. Treco, Vaishnavi Rajagopal, Ketki Ashok Dhamnaskar, Zhong Ma, Susan Ashwell, Jennifer Davoren, Xiaorong Liu, Camil Sayegh, Wenqing Xu, Alex Lemire, Audrey Belouin, Alexandria Jeanneret, Andrew Hildering, Barbara Bertani, Fabrizio MIcheli, Bemardo Pezzati, Alfonso Pozzan